Key result
Novel fluorescence probes detect heparin with high sensitivity down to ~10 nM.
Why the study?
Precise and fast detection of heparin remains a significant challenge for assessing its clinical use.
Novel asymmetric cyanine probes provide a sensitive and selective platform for quantifying heparin and its antidote protamine, which may aid future clinical monitoring.
Answers are grounded in this paper and cite their sources.
May aid heparin/protamine monitoring in samples; extends cyanine platform but leaves open clinical validation.
The precise and fast detection of heparin, the most widely used anticoagulant, remains a significant challenge for assessing its use in a clinical setting. In this work, we adapt a well-established asymmetric cyanine fluorogenic platform for the purpose of ultrasensitive heparin detection in the presence of common interferant chemical species. Three analogous fluorescence probes are synthesized in order to optimize for the number of binding moieties. Their interaction with heparin is studied using steady-state absorption, fluorescence, and circular dichroism spectroscopy. The obtained probes exhibit a highly sensitive "turn-on" fluorescence response to heparin, with a LOD in the 10-25 nM range, well within practical requirement, as well as a visible colorimetric change. The heparin-probe complex is also employed as a sensitive detection platform for protamine, both in the "turn-off" fluorescence and ratiometric detection schemes.
No takes yet. Share an insight, caveat, or question.
Kostadinov et al. (2025) studied this question. Aggregachromic Fluorogenic Asymmetric Cyanine Probes was evaluated on Limit of detection (LOD) for heparin (LOD 10-25 nM). Three novel fluorescence probes exhibited a highly sensitive turn-on fluorescence response to heparin, with a limit of detection in the 10-25 nM range.
Synapse has enriched 10 related papers. Consider them for comparative context: